Literature DB >> 7480082

PAF effects on eicosanoid release in neonatal rat cardiomyocytes.

K Becker1, I Heinroth-Hoffmann, C Giessler, K Pönicke, O E Brodde.   

Abstract

The aim of this study was to find out whether, in neonatal rat cardiomyocytes, platelet-activating factor (PAF) can stimulate eicosanoid formation. For this purpose neonatal cardiomyocytes were incubated for 60 min at 37 degrees C in HANKS buffer with PAF (10-1000 nM), and the eicosanoids thromboxane A2 (TXA2) and prostacyclin (PGI2) were assessed in the supernatant as TXB2 and 6-keto-PGF1 alpha, respectively, by an enzyme immunoassay. PAF caused concentration-dependent release of PGI2; TXA2, however, was significantly released only at the highest concentration of PAF (1000 nM). Acetylsalicylic acid (556 microM) and the PAF antagonist WEB 2086 (10 microM) significantly attenuated PAF-induced eicosanoid formation. We conclude that in neonatal rat cardiomyocytes PAF can induce eicosanoid formation and this effect is brought about by activation of a specific PAF receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7480082     DOI: 10.1016/0952-3278(95)90116-7

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  2 in total

1.  Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2.

Authors:  Kyriakos N Papanicolaou; John M Streicher; Tomo-O Ishikawa; Harvey Herschman; Yibin Wang; Kenneth Walsh
Journal:  J Mol Cell Cardiol       Date:  2010-04-24       Impact factor: 5.000

Review 2.  Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease.

Authors:  Hang Yin; Anhua Shi; Junzi Wu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-07-08       Impact factor: 3.249

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.